Admission Date:  [**2146-3-4**]              Discharge Date:   [**2146-3-16**]  Date of Birth:  [**2094-10-6**]             Sex:   F  Service: SURGERY  Allergies: Patient recorded as having No Known Allergies to Drugs  Attending:[**First Name3 (LF) 6346**] Chief Complaint: nausea, emesis, and abdominal pain  Major Surgical or Invasive Procedure: none   History of Present Illness: 51 year old female recently discharged from [**Hospital1 18**] after hospitalization for a right-sided retroperitoneal hematoma, nausea, emesis, and obstructive symptoms and re-admitted for continued nausea, emesis, and abdominal pain.
Physical Exam: On admission Tc 98.0, HR 122, BP 164/104, RR 18, O2sat 100% Genl: NAD CV: tachycardic Resp: CTA-B Abd: soft, diffusely tender, non-distended; no rebound, no guarding Extr: no c/c/e  At discharge  Gen: AOX3, NAD CV: RRR Lung: CTAB Abd: soft non tender, non-distended, no rebound, no guarding Extra: non c/c/e  Pertinent Results: [**2146-3-4**] 10:30PM   GLUCOSE-150* UREA N-17 CREAT-0.7 SODIUM-138 POTASSIUM-3.4 CHLORIDE-100 TOTAL CO2-20* ANION GAP-21* [**2146-3-4**] 10:30PM   ALT(SGPT)-190* AST(SGOT)-120* ALK PHOS-172* TOT BILI-1.1 [**2146-3-4**] 10:30PM   LIPASE-103* [**2146-3-4**] 10:30PM   ALBUMIN-4.8 CALCIUM-10.5* PHOSPHATE-1.1*# MAGNESIUM-1.8 [**2146-3-4**] 10:30PM   ASA-NEG ETHANOL-NEG ACETMNPHN-NEG bnzodzpn-NEG barbitrt-NEG tricyclic-NEG [**2146-3-4**] 10:30PM   WBC-8.7# RBC-3.91* HGB-11.6*# HCT-33.4* MCV-85 MCH-29.6 MCHC-34.6 RDW-13.4 [**2146-3-4**] 10:30PM   NEUTS-72.0* LYMPHS-23.7 MONOS-3.5 EOS-0.5 BASOS-0.3 [**2146-3-4**] 05:14AM   GLUCOSE-88 UREA N-18 CREAT-0.6 SODIUM-138 POTASSIUM-4.5 CHLORIDE-104 TOTAL CO2-24 ANION GAP-15 [**2146-3-4**] 05:14AM   GLUCOSE-88 UREA N-18 CREAT-0.6 SODIUM-138 POTASSIUM-4.5 CHLORIDE-104 TOTAL CO2-24 ANION GAP-15 [**2146-3-4**] 05:14AM   estGFR-Using this [**2146-3-4**] 05:14AM   CALCIUM-9.0 PHOSPHATE-5.0* MAGNESIUM-2.0 [**2146-3-3**] 04:41AM   GLUCOSE-115* UREA N-16 CREAT-0.5 SODIUM-136 POTASSIUM-4.5 CHLORIDE-104 TOTAL CO2-25 ANION GAP-12 [**2146-3-3**] 04:41AM   CALCIUM-8.7 PHOSPHATE-4.2 MAGNESIUM-2.0  Brief Hospital Course: The patient was initially admitted to the General Surgical Service on [**2146-2-25**] for evaluation and treatment of a retroperitoneal bleed and readmitted on [**2146-3-4**] shortly after discharge for recurrence of symptoms.
The patient was admitted, made NPO, started on IV fluids, and given both IV zofran and compazine for nausea.
Neuro: The patient received anti-emetics and a dilaudid PCA for nausea and pain, respectively, with adequate effect.
When tolerating oral intake, the patient was transitioned to oral pain medications with continued good effect.
GI/GU/FEN: Upon admission, the patient was made NPO with IV fluids started, an NG tube was placed, and supportive care for her symptoms was provided.
Patient experienced significant improvement in her symptoms during the course of this admission and when GI symptoms resolved, diet was advanced to regular with good tolerance and TPN was discontinued and [**2146-3-15**].
Endocrine: While on TPN, the patient's blood sugar was monitored throughout her stay; sliding scale insulin was administered when indicated.
She did not require exogenous insulin at discharge.
As above, an endocrine consult was obtained for evaluation of elevated metanephrines with determination of low suspicion of pheochromocytoma and instructions to follow-up as outpatient after discontinuation of prochlorperazine for 2-3 weeks.
Hematology: Patient was hemodynamically stable during this admission and required no blood transfusions.
Prophylaxis: Venodyne boots and twice daily subcutaneous heparin were used during this admission; she was encouraged to get up and ambulate as early and frequently as possible.
Venlafaxine 150 mg Capsule, Sust.
Release 24 hr PO QAM (in the morning) and 1 capsule PO QPM (at bedtime).
Colace 100 mg Capsule Sig: One (1) Capsule PO twice a day as needed for constipation.
Pantoprazole 40mg DAILY .
Fluoxetine 10 mg PO DAILY .
Oxycodone 5 mg Tablet Sig: 1-2 Tablets PO Q4H as needed for pain.
Venlafaxine 75 mg Capsule, Sust.
Release 24 hr PO QPM (once a day (in the evening)).
Venlafaxine 75 mg Capsule, Sust.
Release 24 hr PO QAM (once a day (in the morning)).
Pantoprazole 40 mg Tablet, Delayed Release (E.C.)
Please refrain from taking prochlorperazine 1 month prior to your appointment.
